PURDUE PHARMA L.P.
Patent Owner
Stats
- 463 US PATENTS IN FORCE
- 53 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 463 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 32,332 Total Citation Count
- Jul 18, 1986 Earliest Filing
- 179 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0022,786 NOVEL SODIUM CHANNEL BLOCKING PEPTIDES AND THE USE THEREOFJul 14, 17Jan 25, 18[A61K, C07K]
2017/0246,194 Acetaminophen-Containing Analgesic Formulations With Reduced HepatotoxicityAug 14, 15Aug 31, 17[A61K]
2017/0231,978 MATRIX FOR SUSTAINED, INVARIANT AND INDEPENDENT RELEASE OF ACTIVE COMPOUNDSApr 28, 17Aug 17, 17[A61K]
2017/0233,400 METHODS FOR MAKING 3-O-PROTECTED MORPHINONES AND 3-O-PROTECTED MORPHINONE DIENOL CARBOXYLATESMay 04, 17Aug 17, 17[C07D]
2017/0224,676 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINEApr 27, 17Aug 10, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9902726 Pyridone-sulfone morphinan analogs as opioid receptor ligandsSep 12, 14Feb 27, 18[A61K, C07D, C07B]
9890164 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulatorsSep 18, 15Feb 13, 18[C07D]
9884059 Systems and methods for treating an opioid-induced adverse pharmacodynamic responseMar 26, 15Feb 06, 18[A61K]
9878991 TRPV1 antagonists including dihydroxy substituent and uses thereofJun 10, 16Jan 30, 18[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0175,447 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINEAbandonedFeb 25, 16Jun 23, 16[A61K, A61M]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.